Trump Administration Weighs Order On Autism And Vaccines - Bloomberg Aug 6, 2026 04:36PM
Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) Following FDA Approval of mRNA Flu Vaccine Aug 6, 2026 08:42AM
FDA approves Moderna's mRNA influenza vaccine for adults 50 and older Aug 5, 2026 10:15PM
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA Aug 5, 2026 10:15PM
Moderna begins Phase 1 trial of Bundibugyo ebolavirus vaccine Aug 4, 2026 11:01AM
View Older Stories

Aug 4, 2026 11:00AM Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Aug 3, 2026 10:05AM Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
Aug 1, 2026 10:00AM U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
Jul 31, 2026 07:01AM Moderna (MRNA) Tops Q2 EPS by 6c, Beats on Revenue
Jul 31, 2026 07:00AM Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
Jul 20, 2026 05:34AM Moderna (MRNA) PT Raised to $25 at Wolfe Research
Jul 16, 2026 07:01AM Moderna doses first patient in Phase 1 trial for mRNA-4200 cancer therapy
Jul 16, 2026 07:00AM Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors
Jul 10, 2026 11:12AM JPMorgan analysts name top short ideas for third quarter 2026
Jul 10, 2026 10:42AM Moderna (MRNA) call put ratio 3.5 calls to 1 put with a focus on July 72 and 77 calls as share price down 9.5%
Jul 9, 2026 07:00AM Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
Jul 8, 2026 07:01AM Moderna adds former Biogen CFO Michael McDonnell to its board
Jul 8, 2026 07:00AM Moderna Appoints Michael McDonnell to Board of Directors
Jul 2, 2026 10:59AM Moderna (MRNA) call put ratio 5 calls to 1 put with a focus on July 10 weekly 80 and 85 calls as share price up 6.5%
Jun 26, 2026 10:42AM Moderna (MRNA) call put ratio 6.7 calls to 1 put with a focus on July 2 weekly 68 and 72 calls as share price up 11.5%
Jun 26, 2026 09:25AM Moderna (MRNA) PT Raised to $77 at Piper Sandler
Jun 26, 2026 07:00AM From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
Jun 25, 2026 04:40PM Moderna outlines three-horizon growth strategy at 2026 Science Day
Jun 25, 2026 07:01AM Moderna outlines mRNA pipeline progress at Science Day event
Jun 25, 2026 07:00AM Moderna Science Day Highlights Expanding Potential of mRNA Platform
Jun 18, 2026 04:00PM FDA advisory panel votes 9-0 in favor of Moderna's mRNA flu vaccine
Jun 18, 2026 04:00PM Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine
Jun 18, 2026 02:43PM Moderna Wins Fda Panel Backing For Mrna Flu Vaccine
Jun 17, 2026 07:00AM Moderna to Host Investor Event - Science Day
Jun 16, 2026 01:50PM Moderna shares gain after FDA staff backs flu vaccine data
Jun 16, 2026 07:33AM Moderna names new CCO and expands president's role ahead of product launches
Jun 16, 2026 07:30AM Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028
Jun 8, 2026 07:01PM Moderna and Oxford receive UK authorization for Lynch syndrome cancer vaccine trial
Jun 8, 2026 07:01PM Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome
Jun 3, 2026 02:14PM Moderna (MRNA) sees strong intraday gains
Jun 2, 2026 07:00AM Moderna to Present at Upcoming Conference in June 2026
Jun 1, 2026 08:01AM Moderna and Merck report sustained melanoma treatment benefits at 5 years
Jun 1, 2026 08:00AM Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASC
Jun 1, 2026 05:49AM Moderna receives $50 million from CEPI for Bundibugyo Ebola vaccine
Jun 1, 2026 05:00AM Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
May 26, 2026 09:15AM UBS Reiterates Neutral Rating on Moderna (MRNA)
May 21, 2026 02:06PM Moderna (MRNA) call put ratio 14 calls to 1 put with a focus on May 22 weekly 52, 55 and 57 calls
May 18, 2026 11:32AM Colorado public health officials investigating hantavirus death not linked to cruise ship cluster - ABC
May 15, 2026 12:55PM High School student in New York linked to suspected hantavirus case - Local report
May 14, 2026 02:12PM No Cases Of Hantavirus Infection In The US - CDC
May 12, 2026 05:00PM Moderna Recognized by TIME as One of the World's Most Impactful Companies
May 12, 2026 12:53PM FDA Commissioner Marty Makary to step down - Politico
May 12, 2026 12:06PM WHO expects additional cases of hantavirus, but no wider outbreak seen
May 12, 2026 08:42AM Bernstein: 'Hantavirus boosting interest in Moderna (MRNA)'
May 11, 2026 11:25AM 1 Hantavirus Suspected Case In Nebraska Is Dual US-UK Citizen - Bloomberg
May 11, 2026 10:23AM HHS downplays Hantavirus risk amid repatriation efforts
May 11, 2026 06:53AM Moderna shares jump 8% after U.S. national tests positive for hantavirus
May 11, 2026 06:25AM Moderna (MRNA) call put ratio 7.4 calls to 1 put amid wide price movement
May 11, 2026 06:09AM Stocks expected to have increasing option volume: CRCL PBR B CEG SPG HIMS MOS PLUG MNDY ASTS FOXA DELL MRNA
May 8, 2026 12:29PM Moderna Is Working On Early-stage Hantavirus Vaccines - Bloomberg
View Older Stories